NCT04720131 2024-01-30
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.
Beijing Friendship Hospital
Phase 2 Completed
Clinical Trials
5 trialsNCT04642664 2021-06-03
ACABC
Peking Union Medical College Hospital
Phase 2 Completed
NCT03609489 2018-08-09
A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 2 Unknown
NCT03427242 2018-02-09
Apatinib for Advanced Biliary Carcinoma
Fudan University
Phase 2 Unknown
NCT03144856 2017-05-09
Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers
Sun Yat-sen University
Phase 2 Unknown